Review
Accepted on 05 Jun 2026
Cholinergic Regulation of Neuroinflammation: Linking Microglia, Immunometabolism, and Neuromodulation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Type at least 3 characters
1,603 articles
articles
Original Research
Accepted on 05 Jun 2026
Clinical Outcomes and Safety of Efgartigimod in Guillain–Barré Syndrome: A Retrospective Observation Study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Review
Accepted on 05 Jun 2026
Smoking Accelerates Immunosenescence in Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Hypothesis and Theory
Accepted on 05 Jun 2026
Multiple sclerosis and the limits of classical autoimmune theory
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Original Research
Published on 05 Jun 2026
Residual inflammation in the cerebrospinal fluid after short- and long-term natalizumab treatment in relapsing-remitting multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1817671
- 611 views
Review
Published on 05 Jun 2026
Chronic spontaneous cholinergic urticaria: advances in immunological mechanisms focusing on neuro-immune crosstalk and novel targeted therapeutic strategies
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1848638
- 812 views
Brief Research Report
Accepted on 04 Jun 2026
Longitudinal Assessment of sNfL and sGFAP in Severe NMOSD Treated with Allogeneic Stem Cell Transplantation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Review
Published on 04 Jun 2026
Neuroimmune cross-talk in Leptospira-associated acute encephalopathy syndrome
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1831261
- 886 views
Perspective
Accepted on 03 Jun 2026
Multiple Sclerosis as an Asynchronous Neuroinflammatory System
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Review
Accepted on 02 Jun 2026
GLP-1 Receptor Agonists in Neurological Diseases: Mechanisms and Therapeutic Prospects from Metabolism to Neuroprotection
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 112 views
Review
Accepted on 31 May 2026
Neuro-immune interactions in cancer: mechanisms and therapeutic prospects
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 116 views
Original Research
Accepted on 29 May 2026
Unraveling immune-inflammation-aging network interactions: an interpretable machine learning model predicts the risk of postherpetic neuralgia
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 303 views
Original Research
Published on 29 May 2026
Age at onset distinguishes clinical features and relapse risk in autoimmune glial fibrillary acidic protein astrocytopathy
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1856124
- 322 views
Case Report
Published on 29 May 2026
Behind the mask of relapsing bimodal encephalitis: herpesvirus 7 and Epstein-Barr virus associated with Hashimoto’s encephalopathy: a case report
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1782631
- 504 views
Clinical Trial
Published on 29 May 2026
Disease outcomes with ublituximab in treatment-naĂŻve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1771848
- 855 views
Original Research
Published on 29 May 2026
Kappa free light chain index in multiple sclerosis and other inflammatory CNS diseases: a pilot single-center study from Argentina
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1803446
- 966 views
Mini Review
Published on 29 May 2026
T cell-microglial interactions that impair myelin maintenance and regeneration: cellular mechanisms on white-matter associated changes
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1813048
- 850 views
Original Research
Published on 29 May 2026
Role of BDNF in form-deprivation myopia progression in guinea pigs
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1733238
- 503 views
Editorial
Published on 28 May 2026
Editorial: Unraveling protein misfolding and innate immunity in neurodegenerative diseases
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1873694
- 663 views
Original Research
Published on 28 May 2026
Distinct roles of dopamine receptors in HIV latency reversal in a myeloid cell model
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1817754
- 521 views
Original Research
Published on 28 May 2026
CXCL9 associates with experimental neuromyelitis optica spectrum disorder following adoptive transfer of Tfh and Th17 cells
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1704040
- 576 views
Original Research
Accepted on 27 May 2026
TPPU protects against seizures and seizure-associated comorbidities by inhibiting the Akt/mTOR signaling pathway in KA-induced convulsant mice
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 164 views
Original Research
Accepted on 26 May 2026
Anti-MOG IgG in EAE models clinical aspects of pediatric MOGAD
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 319 views
Original Research
Accepted on 26 May 2026
A Multi-Omics Framework Integrating Gut Microbiota, Blood Metabolites, and Immune Cells to Elucidate the Pathogenesis of Alzheimer's Disease
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 286 views